Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine
American Chemical Society
3886 - 3899
Item Usage Stats
Recent research has demonstrated that all body fluids assessed contain substantial amounts of vesicles that range in size from 30 to 1000 nm and that are surrounded by phospholipid membranes containing different membrane microdomains such as lipid rafts and caveolae. The most prominent representatives of these so-called extracellular vesicles (EVs) are nanosized exosomes (70-150 nm), which are derivatives of the endosomal system, and microvesicles (100-1000 nm), which are produced by outward budding of the plasma membrane. Nanosized EVs are released by almost all cell types and mediate targeted intercellular communication under physiological and pathophysiological conditions. Containing cell-type-specific signatures, EVs have been proposed as biomarkers in a variety of diseases. Furthermore, according to their physical functions, EVs of selected cell types have been used as therapeutic agents in immune therapy, vaccination trials, regenerative medicine, and drug delivery. Undoubtedly, the rapidly emerging field of basic and applied EV research will significantly influence the biomedicinal landscape in the future. In this Perspective, we, a network of European scientists from clinical, academic, and industry settings collaborating through the H2020 European Cooperation in Science and Technology (COST) program European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD), demonstrate the high potential of nanosized EVs for both diagnostic and therapeutic (i.e., theranostic) areas of nanomedicine.
Science and Technology
Clinical trial (topic)
Drug delivery system
Clinical Trials as Topic
Drug Delivery Systems
Published Version (Please cite this version)https://doi.org/10.1021/acsnano.5b08015
Showing items related by title, author, creator and subject.
Artificial neural network modeling and simulation of in-vitro nanoparticle-cell interactions Cenk, N.; Budak, G.; Dayanik, S.; Sabuncuoglu, I. (American Scientific Publishers, 2014)In this research a prediction model for the cellular uptake efficiency of nanoparticles (NPs), which is the rate that NPs adhere to a cell surface or enter a cell, is investigated via an artificial neural network (ANN) ...
Analysis of the in vitro nanoparticle–cell interactions via a smoothing-splines mixed-effects model Dogruoz, E.; Dayanik, S.; Budak, G.; Sabuncuoglu, I. (Taylor and Francis, 2016)A mixed-effects statistical model has been developed to understand the nanoparticle (NP)–cell interactions and predict the rate of cellular uptake of NPs. NP–cell interactions are crucial for targeted drug delivery systems, ...
Conjugated polymer nanoparticles Tuncel, D.; Demir, Hilmi Volkan (2010)Conjugated polymer nanoparticles are highly versatile nano-structured materials that can potentially find applications in various areas such as optoelectronics, photonics, bio-imaging, bio-sensing and nanomedicine. Their ...